abstract |
: nCompositions comprising compounds, or pharmaceutically acceptable salts, that nmetabolize to monomethyl fumarate (MMF), such as dimethyl fumarate (DMF), and nmethods for treating, prophylaxis, or amelioration of neurodegenerative diseases nincluding multiple sclerosis using such compositions in a subject. |